Dr. Kristen Nooshin Ganjoo, MD is a Internal Medicine Physician - Hematology practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Residency - Indiana University | 1997 | |
| Internship - Indiana University, Bachelor of Science In Business, Bloomington, Indiana | 1995 | |
| Internship - Indiana University | 1995 | |
| Fellowship - Indiana University / School of Medicine | 2000 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 2000 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Oncology) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | Gastrointestil stromal tumors, version 2.2014. | 2014 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines | 2014 |
| Other Publication | Anls of oncology | A multicenter phase II study of pazopanib in patients with advanced gastrointestil stromal tumors | 2014 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | R1507, a Monoclol Antibody to the Insulin-Like Growth Factor 1 Receptor | 2011 |
| Other Publication | DRUGS | Current and Emerging Pharmacological Treatments for Gastrointestil Stromal Tumour | 2011 |
| Other Publication | ONCOLOGY | A Phase I Study of the Safety | 2011 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | NCCN Task Force Report: Update on the Magement of Patients with Gastrointestil Stromal Tumors | 2010 |
| Other Publication | LEUKEMIA & LYMPHOMA | Acute myeloid leukemia in patients with gastrointestil stromal tumors treated with Gleevec | 2009 |
| Other Publication | Leukemia & lymphoma | Bevacizumab and cyclosphosphamide, doxorubicin | 2014 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines | 2012 |
| Other Publication | LEUKEMIA & LYMPHOMA | Cardiac toxicity associated with bevacizumab | 2012 |
| Other Publication | CANCER INVESTIGATION | Maintence Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced | 2012 |
| Other Publication | CLINICAL CANCER RESEARCH | Results of a Phase 1 Study of AME-133v (LY2469298) | 2012 |
| Other Publication | AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study | 2011 |
| Other Publication | JOURL OF THORACIC ONCOLOGY | A Phase II First-Line Study of Gemcitabine, Carboplatin | 2010 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory | 2010 |
| Other Publication | AMERICAN JOURL OF PATHOLOGY | Coordite Expression of Colony-Stimulating Factor-1 | 2009 |
| Other Publication | JOURL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | The importance of angiogenesis markers | 2008 |
| Other Publication | AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | A phase II study of single agent gemcitabine | 2005 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Unusual locations of involvement by maligncies - Case 1. Testicular plasmacytoma | 2003 |
| Other Publication | JOURL OF UROLOGY | Germ cell tumor associated primitive neuroectodermal tumors | 2001 |
| Other Publication | Ganjoo, K. N., Rieger, K. M., Kesler, K. A., Sharma, M., Heilman, D. K | Results of modern therapy for patients with mediastil nonseminomatous germ cell tumors | 2000 |
| Other Publication | Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. | Primary mediastil nonseminomatous germ cell tumors | 1999 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Lung cancer presenting with solitary bone metastases - Case 1 | 1999 |
| Other Publication | Journal of the National Comprehensive Cancer Network | Gastrointestinal stromal tumors, version 2.2014. | 2014 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines | 2014 |
| Other Publication | Annals of oncology | A multicenter phase II study of pazopanib | 2014 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor | 2011 |
| Other Publication | DRUGS | Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour | 2011 |
| Other Publication | ONCOLOGY | A Phase I Study of the Safety | 2011 |
| Other Publication | CURRENT ONCOLOGY REPORTS | New Developments in Targeted Therapy for Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors | 2010 |
| Other Publication | CANCER | Antiangiogenesis Agents in the Treatment of Soft Tissue Sarcomas | 2010 |
| Other Publication | EXPERT OPINION ON PHARMACOTHERAPY | Trabectedin: an anticancer drug from the sea | 2009 |
| Other Publication | LEUKEMIA & LYMPHOMA | Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec | 2009 |
| Other Publication | Leukemia & lymphoma | Bevacizumab and cyclosphosphamide, doxorubicin | 2014 |
| Other Publication | Current oncology reports | The Treatment Outcome for Adult Patients with Ewing's Sarcoma. | 2013 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines | 2012 |
| Other Publication | LEUKEMIA & LYMPHOMA | Cardiac toxicity associated with bevacizumab | 2012 |
| Other Publication | CANCER INVESTIGATION | Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced | 2012 |
| Other Publication | CLINICAL CANCER RESEARCH | Results of a Phase 1 Study of AME-133v (LY2469298) | 2012 |
| Other Publication | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study | 2011 |
| Other Publication | JOURNAL OF THORACIC ONCOLOGY | A Phase II First-Line Study of Gemcitabine, Carboplatin | 2010 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory | 2010 |
| Other Publication | CANCER | Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory | 2010 |
| Other Publication | Clement-Duchene, C., Krupitskaya, Y., Ganjoo, K., Lavori, P., Kumar, A | A phase II first line study of gemcitabine | 2009 |
| Other Publication | AMERICAN JOURNAL OF PATHOLOGY | Coordinate Expression of Colony-Stimulating Factor-1 | 2009 |
| Other Publication | Krupitskaya, Y., Ganjoo, K., Lavori, P. W., Kumar, A., Clement-Duchene | A phase II first-line study of gemcitabine, carboplatin | |
| Other Publication | Case reports in oncology | Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. | 2009 |
| Other Publication | Case Reports in Oncology | Breast angiosarcomas: Case series and expression of vascular endothelial growth factor | 2009 |
| Other Publication | LEUKEMIA & LYMPHOMA | Opportunistic enteroviral meningoencephalitis | 2009 |
| Other Publication | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | The importance of angiogenesis markers | 2008 |
| Other Publication | Biologics; Targets & Therapy | Review of erlotinib in the treatement of advanced non-small cell lung cancer | |
| Other Publication | Biologics : targets & therapy | Review of erlotinib in the treatment of advanced non-small cell lung cancer. | 2007 |
| Other Publication | CANCER | Non-Hodgkin lymphoma of the breast | 2007 |
| Other Publication | LEUKEMIA & LYMPHOMA | Antiangiogenesis: A new approach to the treatment of lymphoma | 2007 |
| Other Publication | LEUKEMIA & LYMPHOMA | Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety | 2006 |
| Other Publication | CANCER | Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein | 2006 |
| Other Publication | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | A phase II study of single agent gemcitabine | 2005 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Unusual locations of involvement by malignancies - Case 1. Testicular plasmacytoma | 2003 |
| Other Publication | ONCOLOGY | Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer | 2003 |
| Other Publication | ONCOLOGY | A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer | 2002 |
| Other Publication | JOURNAL OF UROLOGY | Germ cell tumor associated primitive neuroectodermal tumors | 2001 |
| Other Publication | Ganjoo, K. N., Rieger, K. M., Kesler, K. A., Sharma, M., Heilman, D. K | Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors | 2000 |
| Other Publication | Ganjoo, K. N., Chan, R. J., Sharma, M., Einhorn, L. H. | Positron emission tomography scans in the evaluation of postchemotherapy residual m | 1999 |
| Other Publication | Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. | Primary mediastinal nonseminomatous germ cell tumors | 1999 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Lung cancer presenting with solitary bone metastases - Case 1 | 1999 |
Accepts New Patients: Yes
Dr. Kristen Nooshin Ganjoo, MD has not yet listed the medications that she commonly prescribes.
